IRS
MYGN icon

Invictus RG (Singapore)’s Myriad Genetics MYGN Stock Holding History

Invictus RG (Singapore)’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-258
Closed -$10K – 682
2014
Q3 		$10K Sell
258
-8,402
-97% -$313K 0.01% 543
2014
Q2 		$337K Buy
8,660
+2,252
+35% +$83.8K 0.35% 74
2014
Q1 		$219K Buy
6,408
+463
+8% +$14.3K 0.26% 141
2013
Q4 		$125K Buy
5,945
+5,168
+665% +$131K 0.09% 328
2013
Q3 		$18K Buy
+777
New +$22.1K 0.02% 560

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invictus RG (Singapore)'s MYGN Position: Q4 2014 in Review

Invictus RG (Singapore) sold out of Myriad Genetics (MYGN) in Q4 2014, closing a stake of 258 shares — an estimated $10K sold.

Invictus RG (Singapore) first reported a position in MYGN in Q3 2013 and held it in 5 quarters. The position peaked at $337K in Q2 2014. 272 funds tracked by Wall St. Rank hold MYGN as of Q4 2014.

  • Invictus RG (Singapore) reported no remaining Myriad Genetics position as of Q4 2014 after selling out during the quarter.
  • Invictus RG (Singapore) sold 258 Myriad Genetics shares in Q4 2014, an estimated $10K.
  • Invictus RG (Singapore) first reported a position in Myriad Genetics in Q3 2013 and held it in 5 quarters.
  • Invictus RG (Singapore)'s Myriad Genetics position peaked at $337K in Q2 2014.
  • 272 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2014.

Based on Invictus RG (Singapore)'s 13F filing for Q4 2014, filed 13 Feb 2015.